Community/Retail

For fourth-year residency candidates across the nation, January through March is often a whirlwind of presentations, program overviews, panels, and a plethora of questions.

Camber recently announced the FDA approval of Tolterodine Tartrate ER capsules, a generic version of Detrol LA (tolterodine, Pharmacia & Upjohn).

Pharmacy DIR fees increasingly are being misused by payers to retroactively claw back reimbursement to pharmacies for the prescription drugs that they provide to Medicare beneficiaries.

An FDA Advisory Committee has recommended the agency’s approval of Janssen’s esketamine nasal spray CIII (Spravato) for adults living with treatment-resistant depression.

The generic product (Wixela Inhub, Mylan) will be offered in 3 strengths at wholesale acquisition costs that are 70% less than the brand equivalent Advair Diskus, according to Mylan.

Daratumumab was first approved in November 2015 as the first and only CD38-directed antibody for the treatment of patients with multiple myeloma who have received at least 3 prior lines of therapy, including a proteasome inhibitor (PI) and an immunomodulatory agent, or who are double refractory to both.

ICI therapy offers a new way to treat cancer, yet clinical trials have often excluded those with HIV due to concerns that it may have negative effects, such as virus reactivation.

Flouxetine tablets were approved with the indication of treating multiple mental disorders.

Although many pharmacists are divided when it comes to their job satisfaction, most of them are currently happy with their compensation, according to a recent Pharmacy Times® Salary and Job Satisfaction Survey.

Warning letters and online advisory letters were posted to the agency's website for 58 products, mostly dietary supplements.

Can you solve why this lady had a mysterious heart attack?

Pulmatrix is set to launch a clinical investigation on the product in 2019.

Researchers predict that the changing nature of the epidemic, driven by the illegal use of opioids such as heroin and fentanyl, has reduced the potential impact of programs that target prescription opioids.

Throughout the country, 47 states and Puerto Rico experienced this in the week ended February 2.

The program aims to reduce the amount of illegal or suspect prescription drugs distributed throughout the United States.

The risks are too high for the pharmacy to be cavalier regarding compliance with antifraud laws.

Patients with chronic obstructive pulmonary disease (COPD) who receive a flu vaccine are significantly less likely to be hospitalized with influenza.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Pharmacy Times Continuing Education™ (PTCE), a leader in continuing education for retail, health-system, managed care and specialty pharmacists, has announced the ninth annual Directions in Pharmacy® continuing education conference series, which will take place in 4 major cities across the United States in spring 2019.

To reduce the likelihood of people giving up on PrEP because of difficulty committing to multiple annual visits, a team of investigators created PrEP@Home, a home-based monitoring system that will allow people on the PrEP regimen to meet with their health care providers just once a year, its creators say.

A recent study analyzed how health systems utilize and integrate virtual care into their daily practice.

Under the rule, prescription rebates may be passed directly to patients at the pharmacy counter, effectively creating a new safe harbor designed for price reductions at the point of sale.

The disproportionate impact on the US African-American population is highlighted each year on February 7, National Black HIV/AIDS Awareness Day.

Officials with the FDA have approved caplacizumab-yhdp (Cablivi, Sanofi) injection for the treatment of adults with acquired thrombotic thrombocytopenic purpura (aTTP), a rare and life-threatening blood clotting autoimmune disorder.

The 2010 remanufacturing of Purdue Pharma's OxyContin (oxycodone) into an "abuse-deterrent formulation" has been identified as a key contributing factor in opioid abusers switching to heroin injections and the corresponding surge in hepatitis C virus (HCV) infections, according to a new Rand Corporation study.

In this clip, Lee Golden, PharmD from TwelveStone Health shares how his pharmacy is working toward innovative, high quality care with their new infusion center.

Along with providing screenings every Thursday in February, including Valentine’s Day, at MinuteClinlic locations nationwide, CVS has also extended its support to American Heart Association’s Go Red for Women with new $15 million commitment.

Real pharmacists speak out about the alleged fake Walgreens pharmacist.